Wireless MicroPremVitals Button Sensor in the NICU

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre

About this trial

A wireless and miniaturized vital sign (ECG, SpO2, Skin Temperature) sensor system, MicroPremVitals Button Sensors was developed by the Dr. John Rogers Laboratory (QSIB- Northwestern University, Chicago, USA) to facilitate vital sign monitoring in extremely preterm neonates.

Eligibility criteria

Qualifiers

Infants admitted to the NICU with a gestational age of ≥ 22+0 weeks and ≤ 29+6 weeks at birth,

AND >72h of age at time of study,

AND clinically stable,

AND with the Neonatal Nurse Practitioner (i.e., NNP) and Healthcare Team in agreement for the patient to participate in the study.

Disqualifiers

Infants with a skin abnormality that would potentially increase the risk of injury,

patient too unstable or family experiencing too much stress as determined by an attending physician or bedside care team to not be approached for recruitment.

Infants admitted to the NICU with a gestational age of < 22+0 weeks or > 29+6 weeks at birth,

and/or ≤ 72h of age at time of study,

Trial design

Treatments tested in this trial

  • Wireless MicroPremVitals Button Sensor System

Treatment groups

10 Participants
are divided into 2 treatment groups

Sponsors and collaborators

McGill University Health Centre/Research Institute of the McGill University Health Centre

Lead sponsor

Northwestern Querrey Simpson Institute for Bioelectronics (QSIB)

Collaborator